Akèy › Neyofibòm Plexifòm › Maryland
Etid klinik pou Neyofibòm Plexifòm nan Maryland
6 etid pou Neyofibòm Plexifòm ap chèche patisipan nan sit nan Maryland.
Tèks ofisyèl etid la (Anglè)
Development and Validation of Patient Reported Outcome (PRO) Measures for Individuals With Neurofibromatosis 1 (NF1) and Plexiform Neurofibromas (pNFs)
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 5 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT02544022Surveillance for Malignant Transformation of Neurofibromatosis Type 1 (NF1) Related Peripheral Nerve Sheath Tumors (PNST)
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteEtid obsèvasyon
Laj 3 a 120 · Tout sèks · Mizajou Sep 2, 2026 · NCT06222203Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteFaz 1
Laj 3 a 35 · Tout sèks · Mizajou Aug 24, 2026 · NCT02390752A Phase 2, Open-Label Study to Evaluate the Safety and Effects of HLX-1502 in Patients With Neurofibromatosis Type 1
- Johns Hopkins Hospital, Baltimore
Ap rekriteFaz 2
Laj 12 ak plis · Tout sèks · Mizajou Jul 29, 2026 · NCT06541847A Study to Evaluate the Feasibility of a Physiologic Biomarker to Assess Pain and Other Sensory Problems Using Pupillometry in Participants With Neurofibromatosis Type 1 (NF1)
- National Institutes of Health Clinical Center, Bethesda
Ap rekrite
Laj 1 a 120 · Tout sèks · Mizajou Jun 9, 2026 · NCT06507748Selumetinib for the Prevention of Plexiform Neurofibroma Growth in NF Type 1
- Johns Hopkins University, Baltimore
- National Cancer Institute/ National Institutes of Health, Bethesda
Ap rekriteFaz 2
Laj 1 a 8 · Tout sèks · Mizajou May 29, 2026 · NCT06188741Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.